Types of metoprolol
Pro Research Analysisby 
Searched over 200M research papers
Types of Metoprolol: An Overview
Metoprolol is a widely used beta-blocker in cardiovascular medicine, particularly for managing hypertension, ischemic heart disease, and heart failure. This article explores the different types of metoprolol formulations, their pharmacodynamic and pharmacokinetic properties, and their therapeutic uses.
Conventional Metoprolol Formulations
Immediate-Release Metoprolol
Immediate-release metoprolol is typically administered in divided doses throughout the day. It is effective in reducing blood pressure and managing angina pectoris but requires multiple daily doses to maintain therapeutic plasma levels 12.
Controlled Release Metoprolol Formulations
Metoprolol CR/ZOK (Controlled Release/Zero Order Kinetics)
Metoprolol CR/ZOK is designed to release the drug at a constant rate over a 24-hour period, providing sustained and consistent plasma concentrations. This formulation allows for once-daily dosing, improving patient compliance. Clinical studies have shown that metoprolol CR/ZOK effectively reduces blood pressure and provides antianginal efficacy comparable to conventional metoprolol 12.
Metoprolol OROS (Oral Osmotic System)
Metoprolol OROS also offers a controlled release mechanism, maintaining steady plasma levels over 24 hours. It has been shown to achieve similar or greater response rates in hypertensive patients compared to conventional and matrix-based sustained release metoprolol formulations. Additionally, it reduces the frequency of anginal attacks in patients with stable effort angina pectoris 12.
Pharmacodynamic and Pharmacokinetic Properties
Beta-1 Selectivity
Metoprolol is a selective beta-1 adrenoceptor antagonist, which means it primarily affects the heart, reducing heart rate and myocardial oxygen demand without significant effects on beta-2 receptors in the lungs. This selectivity makes it preferable for patients with respiratory conditions like asthma 12.
Pharmacokinetics
Controlled release formulations like metoprolol CR/ZOK and OROS have lower peak plasma concentrations and longer time to peak concentration compared to immediate-release forms. This results in more consistent therapeutic levels and fewer side effects, such as fatigue and bronchoconstriction 12.
Therapeutic Uses
Hypertension
Both conventional and controlled release metoprolol formulations are effective in managing hypertension. Controlled release forms offer the advantage of once-daily dosing, which can improve adherence and maintain more stable blood pressure control 12.
Ischemic Heart Disease
Metoprolol reduces myocardial oxygen demand by lowering heart rate and blood pressure, making it effective in managing angina pectoris. Controlled release formulations provide consistent antianginal effects throughout the day 12.
Heart Failure
Metoprolol CR/XL (extended release) has been shown to improve survival in patients with chronic heart failure. It reduces mortality, sudden death, and hospitalizations due to heart failure, making it a valuable addition to standard heart failure therapy 57.
Post-Myocardial Infarction
Long-term use of metoprolol after a myocardial infarction can reduce the risk of reinfarction and sudden death. Controlled release formulations are particularly beneficial in maintaining therapeutic levels and improving patient outcomes 39.
Conclusion
Metoprolol is available in various formulations, each designed to optimize its therapeutic effects while minimizing side effects. Immediate-release metoprolol requires multiple daily doses, whereas controlled release formulations like metoprolol CR/ZOK and OROS offer the convenience of once-daily dosing with consistent plasma levels. These formulations are effective in managing hypertension, ischemic heart disease, and heart failure, making metoprolol a versatile and essential medication in cardiovascular therapy.
Sources and full results
Most relevant research papers on this topic